Concepedia

Gary A. Piazza

GA

Statistics

Publications

98

Citations

7K

H-Index

47

Active since

1978

Affiliations

University of South Alabama(Current)

USA Mitchell Cancer Institute

University of Alabama at Birmingham

Southern Research Institute

German University in Cairo

Gary A. Piazza is an author at University of South Alabama specializing in pharmacology, oncology, and medicine.

ORCID

Publications per year

1978–2025

98

Publications

98

Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis.

Gary A. Piazza, Alanna L. Kulchak Rahm, Mary F. Krutzsch et al. · PubMed · 1995 · 434 citations

, , +15

Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels.

Gary A. Piazza, David S. Alberts, Lee J. Hixson et al. · PubMed · 1997 · 361 citations

, , +15

Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction.

Gary A. Piazza, A K Rahm, T S Finn et al. · PubMed · 1997 · 354 citations

, , +15

Exisulind induction of apoptosis involves guanosine 3',5'-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated beta-catenin.

William J. Thompson, Gary A. Piazza, Han Li et al. · PubMed · 2000 · 305 citations

, , +16

Niclosamide Suppresses Cancer Cell Growth By Inducing Wnt Co-Receptor LRP6 Degradation and Inhibiting the Wnt/β-Catenin Pathway

Wenyan Lü, Cuihong Lin, Michael J. Roberts et al. · PLoS ONE · 2011 · 225 citations · Full text

, , +13

1–5 of 98